About Actimed
Pipeline
Cachexia
News & Events
Contact
NEWS
Jun 10, 2021
Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round
Management Team and Board
David Ebsworth
Chairman
Robin Bhattacherjee
Chief Executive Officer
Andrew J. Stewart Coats
Founder and Non-Executive Director
Frank Misselwitz
Chief Medical Officer and Non-executive Director
Stefan Wohlfeil
Non-executive Director
Hugh Jackson
Chief Financial Officer